Raymond James Financial Inc. Purchases New Shares in The Cooper Companies, Inc. (NASDAQ:COO)

Raymond James Financial Inc. purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 705,164 shares of the medical device company’s stock, valued at approximately $64,826,000.

A number of other large investors have also added to or reduced their stakes in COO. State Street Corp grew its holdings in Cooper Companies by 1.2% during the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock worth $947,897,000 after acquiring an additional 104,521 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Geode Capital Management LLC grew its holdings in Cooper Companies by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after acquiring an additional 48,559 shares in the last quarter. Victory Capital Management Inc. grew its holdings in Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after acquiring an additional 574,899 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Cooper Companies by 11.9% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after acquiring an additional 194,118 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday. Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Friday. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $111.89.

Cooper Companies Trading Down 6.0 %

Shares of NASDAQ:COO opened at $79.89 on Tuesday. The company has a market cap of $15.94 billion, a PE ratio of 40.97, a P/E/G ratio of 2.25 and a beta of 1.02. The company’s 50-day moving average price is $92.14 and its 200 day moving average price is $99.34. The Cooper Companies, Inc. has a fifty-two week low of $79.74 and a fifty-two week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.